Breaking

Medicus Pharma Ltd. to Present at Biotech Showcase 2026, Advancing SkinJect Program Eli Lilly's Legal Victory Over Noom's GLP-1 Claims BBSW AI Solution Event: Daily Roundup

🇺🇸 Search Americas

Global entity results · articles filtered to FDA

36 intelligence results for “Type 2 diabetes”

4 patents · 11 trials · 12 pipelines · 9 articles

🇺🇸 Americas articles · global entities

Top match · Patent

Compositions for diagnosis and treatment of type 2 diabetes The United States of America, as represented by Secretary of the Navy View profile →

All results

Patents (4)

Compositions for diagnosis and treatment of type 2 diabetes — The United States of America, as represented by Secretary of the Navy
Stem cells for modeling type 2 diabetes — REGENERON PHARMACEUTICALS, INC.
Glucan-encapsulated siRNA for treating type 2 diabetes mellitus — The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof — The Regents of the University of California

Trials (11)

Pipelines (12)

Alogliptin — Takeda · phase 3
Alogliptin and glimepiride — Takeda · phase 3
Alogliptin and metformin — Takeda · phase 3
Alogliptin and pioglitazone — Takeda · phase 3
Alogliptin and voglibose — Takeda · phase 3
DIAMICRON 60MG, comprimé sécable à libération modifiée, Placebo S05762, METFORMIN, Forxiga 10 mg film-coated tablets — The George Institute · phase 3
DULAGLUTIDE , Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide, Tirzepatide — Eli Lilly Co. · phase 3
Dapagliflozin — AstraZeneca · phase 3
Dapagliflozin — AstraZeneca · phase 3
Dapagliflozin 10 mg — AstraZeneca · phase 3
EMPAGLIFLOZIN , DAPAGLIFLOZIN , INSULIN GLARGINE , Placebo to match LY3502970, METFORMIN — Eli Lilly Co. · phase 3
Farxiga® (dapagliflozin) + Onglyza® (saxagliptin) + Metformin Oral Mix Treat type 2 diabetes — Lxo Ireland Designated Activity Company · phase 3

Articles (9)